Doctors and patients continue their search for an effective psoriasis treatment. As this condition is characterised primarily by abnormal skin, and hence noticed by others, those affected not only suffer from the immediate symptoms such as itching and inflammation, but also psychological consequences.
Psoriasis is considered an autoimmune disease – possibly a hereditary form of chronic inflammatory skin disease in which the immune system attacks the body’s skin cells, simulating an injury. The body is thus triggered into constantly generating an excessive amount of new skin cells.
A healthy epidermis may take some four weeks to renew itself, yet for people suffering from psoriasis this process only lasts a few days. As a result, no corneal layer will form, and the scales which typify psoriasis appear on the skin and may later become inflamed. These will mostly be limited to specific areas, e.g. elbows, knees, or hands, and may considerably reduce the skin’s elasticity at the joints. In addition, psoriasis may also proliferate on large areas of the skin.
Conventional types of treatment have so far only enjoyed limited success in relieving or temporarily keeping down the symptoms. Alternative approaches often rely on adapting a patient’s diet. This may certainly be justified, as many doctors think that the disease is caused by genetic factors. However, it might be more helpful to treat the primary problems where they occur. First clinical trials using an extract of natural lactic acid bacteria appear to be promising. They are able to stimulate the growth of healthy bacteria on the skin, thus returning the skin flora to healthy balance. This has been examined in the treatment of atopic dermatitis, among others.
An agent identified and tested in many years of research, ibiotics stimulans, is to be optimised as a medical skin care (ibiotics med) to be used in advanced treatments and also be provided for psoriasis.